190 related articles for article (PubMed ID: 36806225)
1. Loss of viral genome with altered immune microenvironment during tumour progression of Epstein-Barr virus-associated gastric carcinoma.
Kondo A; Shinozaki-Ushiku A; Rokutan H; Kunita A; Ikemura M; Yamashita H; Seto Y; Nagae G; Tatsuno K; Aburatani H; Koinuma D; Ushiku T
J Pathol; 2023 Jun; 260(2):124-136. PubMed ID: 36806225
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics and prognosis of Epstein-Barr virus-associated gastric cancer.
Li LL; Yu AY; Zhu M; Ma LY; Cao MH; Liu WL; Qin XB; Gao C; Han ZX; Wang HM
Arch Virol; 2024 May; 169(5):114. PubMed ID: 38700535
[TBL] [Abstract][Full Text] [Related]
3. Virus-host interactions in carcinogenesis of Epstein-Barr virus-associated gastric carcinoma: Potential roles of lost ARID1A expression in its early stage.
Abe H; Kunita A; Otake Y; Kanda T; Kaneda A; Ushiku T; Fukayama M
PLoS One; 2021; 16(9):e0256440. PubMed ID: 34469459
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-associated gastric cancer: A distinct subtype.
Yang J; Liu Z; Zeng B; Hu G; Gan R
Cancer Lett; 2020 Dec; 495():191-199. PubMed ID: 32979463
[TBL] [Abstract][Full Text] [Related]
5. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma.
Choi SJ; Shin YS; Kang BW; Kim JG; Won KJ; Lieberman PM; Cho H; Kang H
Arch Pharm Res; 2017 Aug; 40(8):894-905. PubMed ID: 28779374
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.
Xu WS; Chan AC; Lee JM; Liang RH; Ho FC; Srivastava G
J Med Virol; 1998 Dec; 56(4):342-50. PubMed ID: 9829640
[TBL] [Abstract][Full Text] [Related]
8. High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma.
Ryan JL; Morgan DR; Dominguez RL; Thorne LB; Elmore SH; Mino-Kenudson M; Lauwers GY; Booker JK; Gulley ML
Lab Invest; 2009 Jan; 89(1):80-90. PubMed ID: 19002111
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of Epstein-Barr virus DNA in plasma and stomach biopsies of patients with gastric cancer.
Sarshari B; Ravanshad M; Rabbani A; Zareh-Khoshchehreh R; Mokhtari F; Khanabadi B; Mohebbi SR; Asadzadeh Aghdaei H
Virus Genes; 2023 Jun; 59(3):351-358. PubMed ID: 36757510
[TBL] [Abstract][Full Text] [Related]
10. Update on Epstein-Barr virus and gastric cancer (review).
Shinozaki-Ushiku A; Kunita A; Fukayama M
Int J Oncol; 2015 Apr; 46(4):1421-34. PubMed ID: 25633561
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and characteristics of Epstein-Barr virus associated gastric carcinoma in Gansu Province, Northwest China with mRNA expression of glycoprotein BMRF2.
Guo C; Wei J; Scott RS; Chen Y; Chen Z; Zhao W; Zhang C; Wang B; Chai C; Dai G; Li M; Zhang F
J Med Virol; 2020 Mar; 92(3):356-363. PubMed ID: 31663617
[TBL] [Abstract][Full Text] [Related]
12. Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma.
Lo YM; Chan WY; Ng EK; Chan LY; Lai PB; Tam JS; Chung SC
Clin Cancer Res; 2001 Jul; 7(7):1856-9. PubMed ID: 11448896
[TBL] [Abstract][Full Text] [Related]
13. CXCR4 induces cell autophagy and maintains EBV latent infection in EBVaGC.
Wang W; Zhang Y; Liu W; Zhang X; Xiao H; Zhao M; Luo B
Theranostics; 2020; 10(25):11549-11561. PubMed ID: 33052232
[No Abstract] [Full Text] [Related]
14. The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer.
Nishikawa J; Iizasa H; Yoshiyama H; Nakamura M; Saito M; Sasaki S; Shimokuri K; Yanagihara M; Sakai K; Suehiro Y; Yamasaki T; Sakaida I
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757548
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus and gastric carcinoma.
Fukayama M
Pathol Int; 2010 May; 60(5):337-50. PubMed ID: 20518883
[TBL] [Abstract][Full Text] [Related]
16. Distribution of the Epstein-Barr virus in the normal stomach and gastric lesions in Thai population.
Wanvimonsuk S; Thitiwanichpiwong P; Keelawat S; Mutirangura A; Kitkumthorn N
J Med Virol; 2019 Mar; 91(3):444-449. PubMed ID: 30229949
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.
Bai Y; Xie T; Wang Z; Tong S; Zhao X; Zhao F; Cai J; Wei X; Peng Z; Shen L
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35241494
[TBL] [Abstract][Full Text] [Related]
18. Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer.
Fukayama M; Kunita A; Kaneda A
Adv Exp Med Biol; 2018; 1045():437-457. PubMed ID: 29896679
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus Infection in Gastric Remnant Carcinoma and Recurrent Gastric Carcinoma in Qingdao of Northern China.
Liu S; Zhao Z; Han L; Liu S; Luo B
PLoS One; 2016; 11(2):e0148342. PubMed ID: 26859565
[TBL] [Abstract][Full Text] [Related]
20. Epstein Barr Virus Infection Can be a Secondary Event in B-Cell Lymphomas: A Review of 338 Cases and a Novel Finding of Zonal EBER+ Tumor Cells Showing Features of Progression From Underlying EBV-negative Lymphoma.
Miller IJ
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):165-173. PubMed ID: 28800008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]